Kim Shapiro
Women's Health · Summerville, SCNPI 1952448706
Payments from drug & device makers
What this record shows
11 manufacturers reported payments, led by Edwards Lifesciences at 43.3% of the total. Reporting peaked in 2022 at $628 and has fallen 96.2% since, to $24 in 2025.
Across 33 payments — averaging $33.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$473
- AbbVie$324
- Medtronic$170
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$24
- Johnson & Johnson$22
- Alnylam Pharmaceuticals Inc.$20
- plus $59 from 5 others
What the payments were for
- Travel & lodging$47343%
- Food & beverage$62057%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 1 | $473 |
| AbbVie | 21 | $324 |
| Medtronic | 3 | $170 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $24 |
| Johnson & Johnson | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Coopersurgical, Inc. | 1 | $13 |
| Ascend Therapeutics US, LLC | 1 | $13 |
| Agile Therapeutics, Inc. | 1 | $12 |
| Organon | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CoreValve Evolut$126
How this compares
$1,093 in reported general payments places this provider in the 85th percentile of 62 women's health providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 26 | $1,551 |
| Metronidazole | 11 | $350 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 27 | $220 |
Paid to pharmacies, not to this prescriber.
Other women's health in Summerville
- Mickayla NeibertSummerville$411
- Kahlil DemonbreunColumbia$32K
- Abigail PothenColumbia$3K
- Christine McMahanAnderson$3K
- Kathryn OdonaldConway$2K
- Jacqueline MooreCharleston$2K
- Erin WilkinsCharleston$2K
- Amanda RubyConway$2K
- Karen ThompsonMyrtle Beach$1K
- Danielle AndrewsGreenville$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.